Coldrif
WHO Issues Urgent Global Alert: Toxic Cough Syrups Linked to Child Deaths in India
Oct 14, 2025 01:49 pm CST
The WHO has issued a global health alert against three contaminated cough syrups from India - Coldrif, Respifresh TR, and ReLife - after 25 children died. The products contain toxic Diethylene Glycol and pose life-threatening risks. Authorities have halted production and initiated recalls while warning healthcare professionals worldwide to report any detections of these dangerous medicines.
Tamil Nadu Authorities Revoke License of Pharmaceutical Firm Linked to Fatal Cough Syrup Cases
Oct 14, 2025 12:31 am CST
The Tamil Nadu Drug Control department has revoked Sresan Pharmaceuticals' manufacturing license following the discovery of over 350 serious violations at their facility. Their 'Coldrif' cough syrup, contaminated with diethylene glycol, caused multiple child deaths in Madhya Pradesh and Rajasthan. The Enforcement Directorate has launched raids at seven Chennai locations as investigations expand into potential financial irregularities related to the distribution of the toxic medication.
Coldrif Cough Syrup Manufacturer Arrested: Owner Charged in Fatal Adulteration Case Linked to Children's Deaths
Oct 09, 2025 01:36 pm CST
The owner of Sresan Pharmaceuticals, Ranganathan Govindan, has been arrested for manufacturing adulterated Coldrif cough syrup linked to at least 20 children's deaths across multiple Indian states. Investigations revealed the syrup contained dangerous levels of diethylene glycol (DEG), a toxic substance used in printing ink and glue manufacturing, at 46-48% against the permitted 0.1%. Nine states have banned the product as authorities expand their investigation into the deadly pharmaceutical scandal.
Deadly Negligence: How 20 Children Died from Toxic Cough Syrup While Madhya Pradesh's Drug Testing System Failed
Oct 08, 2025 11:51 pm CST
In Madhya Pradesh, India, a catastrophic breakdown in the drug regulatory system resulted in 20 children's deaths from toxic cough syrup Coldrif. This tragedy exposes critical failures including drug samples sent by ordinary post, delayed testing, premature safety declarations, and an overwhelmed infrastructure with unused mobile testing units. While Tamil Nadu acted swiftly to ban the dangerous medication, Madhya Pradesh's bureaucratic delays allowed the toxic syrup to claim more lives, revealing systemic issues that remain unresolved even as seven children continue fighting for survival.
FAIMA Urges Health Ministry to Form Central Committee to Investigate Fatal Contaminated Cough Syrup Cases
Oct 08, 2025 09:07 pm CST
The Federation of All India Medical Association (FAIMA) has called for a central investigation committee to examine the deaths of over 20 children in Madhya Pradesh and Rajasthan linked to contaminated Coldrif cough syrup. The medical body emphasized the need for nationwide testing of pediatric medications, improved regulatory coordination, and protection of physicians from premature blame while ensuring pharmaceutical safety standards are enforced.
Medical Body Condemns Scapegoating of Doctor in Madhya Pradesh Cough Syrup Deaths Tragedy
Oct 08, 2025 07:36 pm CST
The Federation of All India Medical Association criticizes authorities for making a doctor the scapegoat in the Madhya Pradesh cough syrup tragedy that claimed 16 children's lives. FAIMA Chief Patron Dr. Rohan Krishnan argues that responsibility lies with regulatory bodies that approved the medication containing ingredients banned for young children, highlighting systemic failures in pharmaceutical safety oversight and government awareness campaigns.
Deadly Oversight: Coldrif Cough Syrup Contains Banned Ingredients Linked to Multiple Child Deaths in India
Oct 08, 2025 02:13 pm CST
An investigation reveals that Coldrif cough syrup, linked to 19 children's deaths in Madhya Pradesh, contains ingredients banned for children under four years and dangerous levels of diethylene glycol. Despite a 2023 government directive requiring warning labels and WHO-GMP certification requirements following global child fatalities from contaminated medications, the manufacturer Sresan Pharmaceuticals continued production with 480 times the permitted toxic chemical level without proper certification.
Deadly Negligence: 11 Children Die from Toxic Cough Syrup in Madhya Pradesh While Officials Delay Action
Oct 05, 2025 05:07 pm CST
An NDTV investigation reveals systemic failures in Madhya Pradesh's health system after 11 children died from Coldrif cough syrup contaminated with 48.6% Diethylene Glycol. While Tamil Nadu authorities identified and banned the toxic medication within 24 hours, Madhya Pradesh officials delayed action for weeks, conducted no autopsies, and took holidays during the crisis, raising serious questions about accountability and public health safety.
Dangerous Diethylene Glycol Contamination Found in 'Coldrif' Cough Syrup: Health Ministry Confirms Safety Risk
Oct 04, 2025 05:44 pm CST
The Health Ministry has confirmed that 'Coldrif' cough syrup manufactured by Sresan Pharma in Tamil Nadu contains diethylene glycol (DEG) exceeding safe limits. This industrial solvent can cause severe kidney damage, liver failure, and death, particularly in children. Both Tamil Nadu and Madhya Pradesh have banned the product while authorities conduct comprehensive investigations at 19 manufacturing sites across six states.
Tamil Nadu Bans Coldrif Cough Syrup Following Child Fatalities in Multiple States
Oct 04, 2025 01:24 am CST
Tamil Nadu authorities have banned the sale of 'Coldrif' cough syrup manufactured by a Chennai-based pharmaceutical company after 11 children died in Madhya Pradesh and Rajasthan. Health officials have collected samples to test for Diethylene Glycol contamination while the Union Health Ministry has advised against prescribing cough medications to children under age 2.